Loading...

BGLC BIONEXUS GENE LAB CORP Delisting Actions 8-K Filing

BNXS

BGLC

BIONEXUS GENE LAB CORP

(BGLC)

2025 8-K

Show Summary

Summary

Shareholder Meeting

Strategic Partnership

Ethereum Strategy

Nasdaq Compliance

Delisting Notification

Director Resignations

Annual Meeting Results

Biogas Collaboration

Strategic Agreement

Expansion Plans

Co-Investment Announcement

Strategic Investment

Amendment of Service Contract

Management Changes

Resignation of CFO

Amendment - Disclosure of F...

Appointment of CEO

Resignation of CEO

Management Changes

Equity Offerings

External Links:

BioNexus Gene Lab Corp announced on April 30, 2025, that it has regained compliance with Nasdaq’s minimum bid price requirement of $1.00 per share, following its stock maintaining this price since April 23, 2025.

AI Assistant

BIONEXUS GENE LAB CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.